These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 27468569)
1. Serum Sialic Acid Concentration and Content in ApoB-Containing Lipoproteins in Liver Diseases. Gudowska M; Gruszewska E; Cylwik B; Panasiuk A; Filisiak R; Szmitkowski M; Chrostek L Clin Lab; 2016; 62(6):1069-74. PubMed ID: 27468569 [TBL] [Abstract][Full Text] [Related]
2. Lipid-bound sialic acid (LSA) in liver diseases of different etiologies. Chrostek L; Cylwik B; Panasiuk A; Brodowska-Adamusiak D; Gruszewska E Ann Hepatol; 2011; 10(2):150-4. PubMed ID: 21502676 [TBL] [Abstract][Full Text] [Related]
3. Changed Profile of Serum Transferrin Isoforms in Liver Diseases. Gudowska M; Gruszewska E; Panasiuk A; Cylwik B; Swiderska M; Filisiak R; Szmitkowski M; Chrostek L Clin Lab; 2017 Feb; 63(2):349-354. PubMed ID: 28182352 [TBL] [Abstract][Full Text] [Related]
4. The changes of sialic acid concentration and content in apolipoprotein B-containing lipoproteins in the sera of alcoholics. Cylwik B; Chrostek L; Brodowska-Adamusiak D; Gruszewska E; Daniluk M; Szmitkowski M Alcohol Alcohol; 2010; 45(5):422-6. PubMed ID: 20663853 [TBL] [Abstract][Full Text] [Related]
5. The concentration of total sialic acid in chronic hepatitis B and C. Gruszewska E; Cylwik B; Gudowska M; Panasiuk A; Flisiak R; Chrostek L Ann Clin Biochem; 2019 Jan; 56(1):118-122. PubMed ID: 30027776 [TBL] [Abstract][Full Text] [Related]
6. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis. Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942 [TBL] [Abstract][Full Text] [Related]
7. Lipid parameters predicting liver function in patients with cirrhosis and after liver transplantation. Tietge UJ; Boker KH; Bahr MJ; Weinberg S; Pichlmayr R; Schmidt HH; Manns MP Hepatogastroenterology; 1998; 45(24):2255-60. PubMed ID: 9951906 [TBL] [Abstract][Full Text] [Related]
8. [The behavior of lipids in acute viral hepatitis and chronic hepatopathies]. Boroń-Kaczmarska A; Lapiński W Z Gesamte Inn Med; 1988 May; 43(9):225-8. PubMed ID: 3136599 [TBL] [Abstract][Full Text] [Related]
9. Plasma lipoprotein alterations in patients with chronic hepatocellular liver disease resulting from alcohol abuse: effects of alcohol intake cessation. Camps J; Pizarro I; Prats E; La Ville A; Turner PR; Masana L; Joven J J Hepatol; 1994 Nov; 21(5):704-9. PubMed ID: 7890883 [TBL] [Abstract][Full Text] [Related]
10. Effect of Extended-Release Niacin on High-Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin-Treated Patients. Yadav R; Liu Y; Kwok S; Hama S; France M; Eatough R; Pemberton P; Schofield J; Siahmansur TJ; Malik R; Ammori BA; Issa B; Younis N; Donn R; Stevens A; Durrington P; Soran H J Am Heart Assoc; 2015 Sep; 4(9):e001508. PubMed ID: 26374297 [TBL] [Abstract][Full Text] [Related]
11. A simple precipitation method for measuring sialic acid in apolipoprotein B-containing lipoproteins in plasma. Shishino K; Yoshioka Y; Hashimoto K; Ochi M; Aono K; Murase M; Osawa H; Makino H; Saheki S Ann Clin Biochem; 2005 Jul; 42(Pt 4):298-300. PubMed ID: 15989730 [TBL] [Abstract][Full Text] [Related]
12. The effect of the severity of liver cirrhosis on the level of lipids and lipoproteins. Chrostek L; Supronowicz L; Panasiuk A; Cylwik B; Gruszewska E; Flisiak R Clin Exp Med; 2014 Nov; 14(4):417-21. PubMed ID: 24122348 [TBL] [Abstract][Full Text] [Related]
13. Lipoproteins, HDL-apolipoproteins, activities of hepatic lipase and lecithin-cholesterol acyltransferase in the plasma of patients with post-alcoholic end-stage liver cirrhosis. Breier C; Lisch HJ; Braunsteiner H Klin Wochenschr; 1983 Sep; 61(18):929-31. PubMed ID: 6632732 [TBL] [Abstract][Full Text] [Related]
14. Clinical significance of serum procalcitonin levels in patients with acute or chronic liver disease. Elefsiniotis IS; Skounakis M; Vezali E; Pantazis KD; Petrocheilou A; Pirounaki M; Papatsibas G; Kontou-Kastellanou C; Moulakakis A Eur J Gastroenterol Hepatol; 2006 May; 18(5):525-30. PubMed ID: 16607149 [TBL] [Abstract][Full Text] [Related]
15. Selected Noninvasive Markers in Diagnosing Liver Diseases. Gudowska M; Gruszewska E; Panasiuk A; Cylwik B; Świderska M; Flisiak R; Szmitkowski M; Chrostek L Lab Med; 2016 Feb; 47(1):67-72. PubMed ID: 26715612 [TBL] [Abstract][Full Text] [Related]
16. [Usefulness of sialic acid determination to differentiation between alcohol abuse and alcoholic liver cirrhosis]. Cylwik B; Brodowska D; Chrostek L; Panasiuk A; Szmitkowski M Pol Merkur Lekarski; 2009 Nov; 27(161):368-71. PubMed ID: 19999798 [TBL] [Abstract][Full Text] [Related]
17. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes. Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863 [TBL] [Abstract][Full Text] [Related]
19. Plasma lipoprotein and apolipoprotein profile in alcoholic patients with and without liver disease: on the relative roles of alcohol and liver injury. Duhamel G; Nalpas B; Goldstein S; Laplaud PM; Berthelot P; Chapman MJ Hepatology; 1984; 4(4):577-85. PubMed ID: 6430773 [TBL] [Abstract][Full Text] [Related]
20. Identification and partial characterization of discrete apolipoprotein B containing lipoprotein particles produced by human hepatoma cell line HepG2. Dashti N; Alaupovic P; Knight-Gibson C; Koren E Biochemistry; 1987 Jul; 26(15):4837-46. PubMed ID: 2822101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]